Cabozantinib | Cometriq (Exelixis, Inc.) | Treatment of progressive, metastatic medullary thyroid cancer (MTC). | Drug Information Portal
|
Thyrotropin alpha | Thyrogen® (Genzyme Corporation) | As an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine imaging in the follow-up of patients with thyroid cancer. | Drug Information Portal
|
Vandetanib | (AstraZeneca Pharmaceuticals LP) | Treatment of asymptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease | Daily Med
|